MB Comment: These are extracts from a secret CDC-sponsored meeting (with drug company reps and pediatricians in attendance). They candidly discuss neurodevelopment disorders resulting from vaccine components.
What they say in private totally contradicts the vaccines-are-safe, mercury-is-good-for-you party line they spout in public. The findings from this secret meeting were suppressed and denied by the vaccine establishment. Read for yourself and make up your own mind if vaccines cause neurological damage.
This transcript is posted on the website of a medical society, the Association of American Physicians and Surgeons.
Association of American Physicians and Surgeons, Inc.
A Voice for Private Physicians Since 1943
Omnia pro aegroto
Selected vaccine authorities from CDC, FDA, and manufacturers discuss, in a closed meeting, the possibility of neurodevelopment disorders resulting from vaccine components.
Emphasis and comments in square brackets added by K.P. Stoller, M.D.
[The CDC published a study in late 2003, repudiating any possible link between thimerosal and developmental problems such as autism, but the CDC did have data supporting such a link which it secretively kept from the public.
Documents released through the Freedom of Information Act detail the transcript of a meeting held in June of 2000 between members of the CDC, the FDA, and representatives from the vaccine industry.
This top secret meeting was held to discuss a study done by Dr. Thomas Verstraeten and his co-workers using Vaccine Safety Datalink data as a project collaboration between the CDC’s National Immunization Program (NIP) and four HMOs. The study examined the records of 110,000 children.
The transcript is titled �Scientific Review of Vaccine Safety Datalink Information,� June 7-8, 2000, Simpsonwood Retreat Center, Norcross, Georgia …
Dr. Johnston, pg. 14-15 & 19-20: (Chair of the meeting and a pediatrician-immunologist at the University of Colorado): �Thimerosal is cleaved (in the body) into ethylmercury and thiosalicylate which is inactive� The data on its toxicity (shows) it can cause neurologic and renal toxicity, including death.� …
�We just recently had another meeting that some of you were able to attend dealing with aluminum in vaccines. I would like to just say one or two words about that before I conclude.�
�We learned at that meeting a number of important things about aluminum, and I think they also are important in our considerations today. �Aluminum salts are important in the formulating process of vaccines, both in antigen stabilization and absorption of endotoxin.�
�Aluminum and mercury are often simultaneously administered to infants, both at the same site and at different sites.�
�However, we also learned that there is absolutely no data, including animal data, about the potential for synergy, additively or antagonism, all of which can occur in binary metal mixtures that relate and allow us to draw any conclusions from the simultaneous exposure to these two salts in vaccines��
Dr. Weil, pg. 24: �I think it�s clear to me anyway that we are talking about a problem that is probably more related to bolus acute exposures, and we also need to know that the migration problems and some of the other developmental problems in the central nervous system go on for quite a period after birth. But from all of the other studies of toxic substances, the earlier you work with the central nervous system, the more likely you are to run into a sensitive period for one of these effects, so that moving from one month or one day of birth to six months of birth changes enormously the potential for toxicity. There are just a host of neurodevelopmental data that would suggest that we�ve got a serious problem. The earlier we go, the more serious the problem.�
�The second point I could make is that in relationship to aluminum, being a nephrologist for a long time, the potential for aluminum and central nervous system toxicity was established by dialysis data. To think there isn�t some possible problem here is unreal.�
Dr. Verstraeten, pg. 40: ��we have found statistically significant relationships between the exposure and outcomes for these different exposures and outcomes. First, for two months of age, an unspecified developmental delay, which has its own specific ICD9 code. Exposure at three months of age, Tics. Exposure at six months of age, an attention deficit disorder. Exposure at one, three and six months of age, language and speech delays which are two separate ICD9 codes. Exposures at one, three and six months of age, the entire category of neurodevelopmental delays, which includes all of these plus a number of other disorders.�
Dr. Weil, pg. 75: �I think that what you are saying is in term of chronic exposure. I think that the alternative scenario is that this repeated acute exposures, and like many repeated acute exposures, if you consider a dose of 25 micrograms on one day, then you are above threshold. At least we think you are, and then you do that over and over to a series of neurons where the toxic effect may be the same set of neurons or the same set of neurologic processes; it is conceivable that the more mercury you get, the more effect you are going to get.� …
Dr. Egan, pg. 77: “Could you do this calculation for aluminum?”
Dr. Verstraeten, pg. 77: “I did it for aluminum�Actually the results were almost identical to ethylmercury because the amount of aluminum goes along almost exactly with the mercury one.” …
Dr. Bernier, pg. 113: “We have asked you to keep this information confidential. We do have a plan for discussing these data at the upcoming meeting of the Advisory Committee of Immunization Practices on June 21 and June 22. At that time CDC plans to make a public release of this information*, so I think it would serve all of our interests best if we could continue to consider these data. The ACIP work group will be considering also. If we could consider these data in a certain protected environment. So we are asking people who have a great job protecting this information up until now, to continue to do that until the time of the ACIP meeting. So to basically consider this embargoed information. That would help all of us to use the machinery that we have in place for considering these data and for arriving at policy recommendations.”
[*This never happened. SafeMind.org obtained this transcript via the Freedom of Information Act. Data published later were diluted into insignificance by including additional data from an HMO that had very uncharacteristic results.]
Dr. Brent, pg. 161: “Wasn’t it true that if you looked at the population that had 25 micrograms you had a certain risk and when you got to 75 micrograms you had a higher risk.”
Dr. Verstraeten, pg. 161: “Yes, absolutely, but these are all at the same time. Measured at the same age at least.” …
Dr. Verstraeten, pg. 161: “Personally, I have three hypotheses. My first hypothesis is it is parental bias. The children that are more likely to be vaccinated are more likely to be picked and diagnosed. Second hypothesis, I don’t know. There is a bias that I have not recognized, and nobody has yet told me about it. Third hypothesis. It’s true, it’s Thimerosal. Those are my hypotheses.”
Dr. Brent, pg. 161: “If it’s true, which or what mechanisms would you explain the finding with?”
Dr. Verstraeten, pg. 162: “You are asking for biological plausibility?”
Dr. Brent, pg. 162: “Well, yes.” …
Dr. Weil, pg. 187 & 188: “Although the data presents a number of uncertainties, there is adequate consistency, biological plausibility, a lack of relationship with phenomenon not expected to be related, and a potential causal role that is as good as any other hypothesized etiology of explanation of the noted associations. In addition, the possibility that the associations could be causal has major significance for public and professional acceptance of Thimerosal containing vaccines. I think that is a critical issue. Finally, lack of further study would be horrendous grist for the anti-vaccination bill. That’s why we need to go on, and urgently I would add.* … …
Dr. Koller, pg. 192: “�As you increase the vaccination, you increase effects, but you don’t know. You have modified live viruses. You have different antigens. There is a lot of things in those vaccinations other than mercury, and we don’t know whether this is a vaccination effect or a mercury effect. …
Dr. Johnson, pg. 198: “This association leads me to favor a recommendation that infants up to two years old not be immunized with Thimerosal containing vaccines if suitable alternative preparations are available.�
�My gut feeling? It worries me enough. Forgive this personal comment, but I got called out at eight o’clock for an emergency call and my daughter-in-law delivered a son by C-section. Our first male in the line of the next generation, and I do not want that grandson to get a Thimerosal containing vaccine until we know better what is going on. It will probably take a long time. In the meantime, and I know there are probably implications for this internationally, but in the meantime I think I want that grandson to only be given Thimerosal-free vaccines.” …
Dr. Brent, pg. 229: “The medical/legal findings in this study, causal or not, are horrendous and therefore, it is important that the suggested epidemiological, pharmacokinetic, and animal studies be performed. If an allegation was made that a child’s neurobehavioral findings were caused by Thimerosal containing vaccines, you could readily find junk scientist who would support the claim with “a reasonable degree of certainty”. But you will not find a scientist with any integrity who would say the reverse with the data that is available. And that is true. So we are in a bad position from the standpoint of defending any lawsuits if they were initiated and I am concerned.”
Dr. Meyers, pg. 231: “Can I go back to the core issue about the research? My own concern, and a couple of you said it, there is an association between vaccines and outcome that worries both parents and pediatricians. We don�t really know what that outcome is, but it is one that worries us and there is an association with vaccines. We keep jumping back to Thimerosal, but a number of us are concerned that Thimerosal may be less likely than some of the potential associations that have been made. Some of the potential associations are number of injections, number of antigens, other additives. We mentioned aluminum and I mentioned yesterday aluminum and mercury. …
Dr. Caserta, pg. 234: “One of the things I learned at the Aluminum Conference in Puerto Rico that was tied into the metal lines in biology and medicine that I never really understood before, is the interactive effect of different metals when they are together in the same organism. It is not the same as when they are alone, and I think it would be foolish for us not to include aluminum as part of our thinking with this.” …
if this committee decides that there is no association and that information gets out, the work that has been done and through the freedom of information that will be taken by others and will be used in ways beyond the control of this group. And I am very concerned about that as I suspect it already too late to do anything regardless of any professional body and what they say.”
“My mandate as I sit here in this group is to make sure at the end of the day the 100,000,000 are immunized with DTP, Hepatitis B and if possible Hib, this year, next year and for many years to come, and that will have to be with Thimerosal containing vaccines unless a miracle occurs and an alternative is found quickly and is tried and found to be safe.” …
Bob Chen, M.D., CDC�s chief of Vaccine Safety and Development, National Immunization Program
Tom Clarkson, M.D., University of Rochester, New York, Mercury program
John Clements, World Health Organization (WHO) representing expanded program on immunization
Bob Davis, M.D., University of Washington, associate professor of pediatrics and epidemiology
Bill Egan, Ph.D., FDA�s Center for Biologics, Evaluation & Research
David Johnson, M.D., Michigan state public health officer, Advisory Committee on Immunization Practices (ACIP)
Dick Johnston, M.D., University of Colorado School of Medicine and National Jewish Center for Immunology and Respiratory Medicine, immunologist and pediatrician
Loren Koller, D.V.M., Oregon State University College of Veterinary Medicine, pathologist, immunotoxicologist
Martin Meyers, M.D., CDC�s acting director, National Immunization Program
Walter Orenstein, M.D. CDC�s director, National Immunization Program
Isabelle Rapin, M.D., Albert Einstein College of Medicine, neurologist for children
Tom Verstraeten, M.D., CDC�s National Immunization Program presently employed by Glaxo-Welcome, vaccine company
Bill Weil, M.D., retired pediatrician, representing American Academy of Pediatrics� (AAP)